EIF4E and hepatocellular carcinoma: To further confirm the correlation of eIF4E with HCC prognosis, we compared overall survival (OS) and disease‐free survival (DFS) times between these two groups, as follows: patients with negative, weak, and moderate staining were stratified as the eIF4E low expression group, and those with strong staining as the eIF4E high expression group.